Min Lin1, Shiowjen Lee1, Boguang Zhen1
11 Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Adaptive clinical trials offer flexibility but require careful planning. This review of FDA Center for Biologics Evaluation and Research (CBER) submissions highlights statistical and operational challenges for adaptive design proposals.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: